Log in to search using one of your social media accounts:


7 medtech stories we missed this week: Sept. 8, 2017

[Image from unsplash.com]From BrainScope’s pediatric traumatic brain injury assessment device to EOS Imaging releasing new surgery planning software, here are seven medtech stories we missed this week but thought were still worth a mention. 1. BrainScope to develop pediatric traumatic brain injury assessment device BrainScope announced in a Sept. 7 press release that it will immediately start creating a pediatric capability for its BrainScope One medical neurotechnology. The technology is an FDA-cleared handheld medical device that is designed to assess the full spectrum of traumatic brain injury. The company says that the pediatric version of its BrainScope One will be similar to the one that is currently available. The current device is easy-to-use and rapid and helps clinicians assess whether a patient has a structural brain injury that can be visible on a CT scan or if a patient has function brain impairment like a concussion. 2. BoneSupport inks French distribution deal BoneSupport announced that it has signed a distribution deal with Novomedics, according to a Sept. 7 press release. The distribution deal intends to help BoneSupport gain access to the French market with its Cerament product line of bone void filler, Cerement G and Cerament V. The commercialization agreement allows for BoneSupport’s products to be sold in 8 key European markets while also directly marketing its products in five European countries in the U.K., Germany, Switzerland, Sweden ...
Source: Mass Device - Category: Medical Devices Authors: Tags: 510(k) Cardiac Assist Devices Cardiovascular Clinical Trials Diagnostics Food & Drug Administration (FDA) Imaging mHealth (Mobile Health) Neurological Regulatory/Compliance Research & Development Spinal AliveCor Bonesupport Bra Source Type: news

Related Links:

A Boston biotech with a unique approach to treating an aggressive brain tumor, Ziopharm Oncology reported this weekend that its combination of experimental drugs has helped 15 patients survive about twice as long as they would have otherwise in an early-stage trial. Ziopharm (Nasdaq: ZIOP) reported the updated trial data in patients with recurrent glioblastoma at the Society for Neuro-Oncology this weekend. The 15 patients are all being treated with Ziopharm’s gene therapy, called Ad-RTS-hIL-12,…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news
Abstract In this work, a new, simple, rapid, and environmentally friendly method with a high sample clean-up capability termed as centrifugeless ultrasound-assisted dispersive micro solid-phase extraction coupled with salting-out ultrasound-assisted liquid-liquid microextraction based on solidification of a floating organic droplet followed by high performance liquid chromatography is introduced for the first time. In this method, the three non-steroidal anti-inflammatory drugs diclofenac, ibuprofen, and mefenamic acid are first extracted based on an effective nanoadsorbent named as the layered double hydroxide-ca...
Source: Analytica Chimica Acta - Category: Chemistry Authors: Tags: Anal Chim Acta Source Type: research
Beneš P, Ranc V, Konvalinka J, Zbořil R Abstract Prostate cancer is one of the most common cancers among men and can in its later stages cause serious medical problems. Due to the limited suitability of current diagnostic biochemical markers, new biomarkers for the detection of prostate cancer are highly sought after. An ideal biomarker should serve as a reliable prognostic marker, be applicable for early diagnosis, and be applicable for monitoring of therapeutic response. One potential candidate is glutamate carboxypeptidase II (GCPII), also known as prostate specific membrane antigen (PSMA), which has a ...
Source: Analytica Chimica Acta - Category: Chemistry Authors: Tags: Anal Chim Acta Source Type: research
In this study, we demonstrated a facile strategy to fabricate a TLC plate with metal-organic framework-modified gold nanoparticles as a separable SERS substrate, on which all separated components, including overlapping and invisible compounds, could be detected by a point-by-point SERS scan along the developing direction. Rhodamine 6G (R6G) was used as a probe to evaluate the performance of the substrate. The results indicated that the substrate provided good sensitivity and reproducibility, and optimal SERS signals could be collected in 5 s. Furthermore, this new substrate exhibited a long shelf life. Thus, our metho...
Source: Analytica Chimica Acta - Category: Chemistry Authors: Tags: Anal Chim Acta Source Type: research
AN UNCOMMON cancer in the UK could be causing your sore throat or tiredness.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
ZURICH (Reuters) - Roche announced two trial wins for its cancer and hemophilia drugs on Monday, boosting its shares and weighing on the stocks of its main rivals.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
We report nine patients with PTEN mutations and white matter changes on brain magnetic resonance imaging (MRI), eight of whom were referred for reasons other than developmental delay or ASD. Their clinical presentations ranged from asymptomatic macrocephaly with normal development/intellect, to obsessive compulsive disorder, and debilitating neurological disease. To our knowledge, this report constitutes the first detailed description of PTEN‐related white matter changes in adult patients and in children with normal development and intelligence. We present a detailed assessment of the neuropsychological phenotype of our ...
Source: American Journal of Medical Genetics Part B: Neuropsychiatric Genetics - Category: Genetics & Stem Cells Authors: Tags: RESEARCH ARTICLE Source Type: research
We would like to tell you about the December issue of the Journal of Vascular Surgery and some of the key articles. The first paper, by Chandra and co-authors from Stanford, entitled “Management and outcomes of symptomatic abdominal aortic aneurysms during the past 20 years,” compares symptomatic patients with abdominal aortic aneurysm (AAA), defined as those who had new onset abdominal pain or aneurysm tenderness with no rupture found by computed tomography scan or in the operating room. In these patients, the repair of AAA was primarily open from 1995 to 2004 and evolved to primarily endovascular repair ...
Source: Journal of Vascular Surgery - Category: Surgery Authors: Tags: Journal of Vascular Surgery – December 2017 Audiovisual Summary Source Type: research
We appreciate the comments on our article “Predictive value of neutrophil-to-lymphocyte ratio in diabetic wound healing.”1 There is an increasing body of evidence for predictability of neutrophil-to-lymphocyte ratio (NLR) for outcomes in different diseases, including cancers and cardiovascular diseases.2,3 We appreciate the attention to our findings, and address the raised concerns as follows.
Source: Journal of Vascular Surgery - Category: Surgery Authors: Tags: Letter to the Editor Source Type: research
Duplex ultrasound (DUS) surveillance of infrainguinal vein bypass grafts is widely practiced, but the evidence of its effectiveness compared with other methods of surveillance remains unclear.
Source: Journal of Vascular Surgery - Category: Surgery Authors: Tags: Review article Source Type: research
More News: Atrial Fibrillation | Brachytherapy | Brain | Brain Cancers | Cancer | Cancer & Oncology | Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Clinical Trials | Concussion | Contracts | CT Scan | Denmark Health | France Health | Germany Health | Heart | Heart Transplant | Information Technology | Mammography | Marketing | Medical Devices | Men | Neurology | Neurosurgery | Pediatrics | PET Scan | Prostate Cancer | Radiography | Study | Sweden Health | Switzerland Health | Ultrasound | Women